{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:55:53Z","timestamp":1792148153742,"version":"4.4.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>ABO blood group compatibility has been regarded as an essential prerequisite for successful adult living donor liver transplantation (LDLT). Novel strategies for overcoming the ABO blood group barrier, however, have markedly improved the results of ABO-incompatible (ABOi) LDLT. We describe our strategies for dual graft LDLT to cope with ABO-incompatibility and small-for-size graft syndrome in 3 patients who underwent dual graft LDLT with ABOi and ABO-compatible (ABOc) grafts. One patient received a modified right lobe graft from an ABOi living donor and a left lateral section graft from an ABOc deceased donor, whereas the other 2 patients received 2 left lobe or left lateral section grafts from ABOi and ABOc living donors. To overcome the ABO-blood barrier, each patient was treated with preoperative anti-CD20 antibody (rituximab 375 mg\/m<jats:sup>2<\/jats:sup>), perioperative plasma exchange, and hepatic arterial infusion. All 3 patients were males, of mean age 47.7 years (range, 40\u223d52 years) and mean Model for End-Stage Liver Disease score 12.3 (range, 9\u223d15). The mean graft-to-recipient weight ratio was 0.99%. All patients remain alive after a mean follow-up period of 9.5 months (range, 8.0\u223d10.7 months). All 6 grafts have functioned normally. There were no episodes of antibody-mediated rejection or biliary complication. Dual LDLT with ABOi and ABOc grafts can be a feasible solution for simultaneously overcoming both the ABO blood group barrier and small-for-size graft syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22016","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T20:18:22Z","timestamp":1263586702000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier"],"prefix":"10.1097","volume":"16","author":[{"given":"Gi-Won","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Gyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Bog","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yong","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seog-Woon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20250326","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00595-008-3771-1","article-title":"Current concept of small-for-size grafts in living donor liver transplantation.","volume":"38","author":"Ikegami","year":"2008","journal-title":"Surg Today"},{"key":"R2-14-20250326","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007890-199901270-00024","article-title":"Impact of graft size mismatching on graft prognosis in liver transplantation from living donors.","volume":"67","author":"Kiuchi","year":"1999","journal-title":"Transplantation"},{"key":"R3-14-20250326","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.sla.0000098618.11382.77","article-title":"Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation.","volume":"238","author":"Fan","year":"2003","journal-title":"Ann Surg"},{"key":"R4-14-20250326","first-page":"15","article-title":"Living donor liver transplantation: present status and recent advances.","volume":"75-","author":"Sugawara","year":"2006","journal-title":"Br Med Bull"},{"key":"R5-14-20250326","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00595-008-3917-1","article-title":"Toward 300 liver transplants a year.","volume":"39","author":"Lee","year":"2009","journal-title":"Surg Today"},{"key":"R6-14-20250326","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan.","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"R7-14-20250326","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/TP.0b013e318173a70e","article-title":"ABO-incompatible living donor liver transplantation: new insights into clinical relevance.","volume":"85","author":"Kawagishi","year":"2008","journal-title":"Transplantation"},{"key":"R8-14-20250326","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","article-title":"Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation.","volume":"73","author":"Tanabe","year":"2002","journal-title":"Transplantation"},{"key":"R9-14-20250326","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/lt.20727","article-title":"ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy.","volume":"12","author":"Troisi","year":"2006","journal-title":"Liver Transpl"},{"key":"R10-14-20250326","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.TP.0000149337.40911.E4","article-title":"Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation.","volume":"79","author":"Usuda","year":"2005","journal-title":"Transplantation"},{"key":"R13-14-20250326","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/lt.21042","article-title":"The first two cases of living donor liver transplantation using dual grafts in Europe.","volume":"13","author":"Broering","year":"2007","journal-title":"Liver Transpl"},{"key":"R14-14-20250326","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1600-6143.2008.02153.x","article-title":"Living donor liver transplantation using dual grafts from two donors: A feasible option to overcome small-for-size graft problems?","volume":"8","author":"Soejima","year":"2008","journal-title":"Am J Transplant"},{"key":"R15-14-20250326","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/lt.20734","article-title":"Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe.","volume":"12","author":"Hwang","year":"2006","journal-title":"Liver Transpl"},{"key":"R16-14-20250326","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1067\/msy.2001.114218","article-title":"An adult-to-adult living donor liver transplant using dual left lobe grafts.","volume":"129","author":"Lee","year":"2001","journal-title":"Surgery"},{"key":"R17-14-20250326","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.TP.0000046532.44975.57","article-title":"Ethics and rationale of living-donor liver transplantation in Asia.","volume":"75","author":"de Villa","year":"2003","journal-title":"Transplantation"},{"key":"R18-14-20250326","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1432-2277.2006.00424.x","article-title":"Current trends in live liver donation.","volume":"20","author":"Nadalin","year":"2007","journal-title":"Transpl Int"},{"key":"R19-14-20250326","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/01.TP.0000063939.81744.3E","article-title":"Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome.","volume":"75","author":"Chisuwa","year":"2003","journal-title":"Transplantation"},{"key":"R20-14-20250326","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.surg.2006.02.019","article-title":"Small remnant liver volume after right lobe living donor hepatectomy.","volume":"140","author":"Ibrahim","year":"2006","journal-title":"Surgery"},{"key":"R21-14-20250326","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-199610000-00012","article-title":"Functional analysis of grafts from living donors. Implications for the treatment of older recipients.","volume":"224","author":"Emond","year":"1996","journal-title":"Ann Surg"},{"key":"R22-14-20250326","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00000658-200104000-00014","article-title":"Small graft for living donor liver transplantation.","volume":"233","author":"Nishizaki","year":"2001","journal-title":"Ann Surg"},{"key":"R23-14-20250326","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/j.1600-6143.2005.01081.x","article-title":"Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications.","volume":"5","author":"Dahm","year":"2005","journal-title":"Am J Transplant"},{"key":"R24-14-20250326","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-6143.2007.02045.x","article-title":"Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good?","volume":"8","author":"Oura","year":"2008","journal-title":"Am J Transplant"},{"key":"R25-14-20250326","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1432-2277.2008.00678.x","article-title":"The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft.","volume":"21","author":"Yoshizumi","year":"2008","journal-title":"Transpl Int"},{"key":"R26-14-20250326","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1600-6143.2005.00850.x","article-title":"Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation.","volume":"5","author":"Troisi","year":"2005","journal-title":"Am J Transplant"},{"key":"R27-14-20250326","first-page":"670","article-title":"Living donor liver transplantation with extra-small graft; inflow modulation using splenectomy and temporary portocaval shunt.","volume":"55","author":"Ikegami","year":"2008","journal-title":"Hepatogastoenterology"},{"key":"R28-14-20250326","first-page":"75","article-title":"Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers.","volume":"15","author":"Lo","year":"2003","journal-title":"Transplant"},{"key":"R29-14-20250326","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.TP.0000065020.55959.4A","article-title":"Donor complications and outcomes in live-liver transplantation.comment.","volume":"75","author":"Otte","year":"2003","journal-title":"Transplantation"},{"key":"R31-14-20250326","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1744-9987.2005.00304.x","article-title":"Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.","volume":"9","author":"Kozaki","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R32-14-20250326","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transpl"},{"key":"R33-14-20250326","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action.","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"R34-14-20250326","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/01.tp.0000296122.19026.0f","article-title":"Pharmacodynamics of rituximab in kidney transplantation.","volume":"84","author":"Genberg","year":"2007","journal-title":"Transplantation"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22016","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201004000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:39:23Z","timestamp":1743266363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201004000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22016","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}